ArticleNature methods2025
EpiAgent: foundation model for single-cell epigenomics.
Article in Nature methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Single-cell epigenomics of colorectal cancer.Experimental & molecular medicine · 2026Review
- Hi-Cformer enables multiscale chromatin contact map modeling for single-cell Hi-C data analysis.Science advances · 2026Article
- Multi-omics-driven precision medicine.iMeta · 2026Review
- Foundation models in omics research: a comprehensive survey.Briefings in bioinformatics · 2026Review
- Computational modelling of cell identity.The Biochemical journal · 2026Review
- Transformers for single-cell RNA sequencing: a survey.Briefings in bioinformatics · 2026Review
- Single-Cell and Spatial Omics: Methods and Applications.MedComm · 2026Review
- Advances in scCUT&Tag and computational analysis for single-cell gene regulatory element mapping.Briefings in bioinformatics · 2026Review
- Human-scATAC-Corpus: a comprehensive database of scATAC-seq data.Nucleic acids research · 2026Article
- Atacformer: A transformer-based foundation model for analysis and interpretation of ATAC-seq data.bioRxiv : the preprint server for biology · 2025Article
- Transformative advances in single-cell omics: a comprehensive review of foundation models, multimodal integration and computational ecosystems.Journal of translational medicine · 2025Review
- Foundation models in plant molecular biology: advances, challenges, and future directions.Frontiers in plant science · 2025Review
- AI for Scientific Discovery in Omics Data-Driven Precision Medicine.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) enables the exploration of the epigenomic landscape that governs transcription at the cellular level, the complicated characteristics of the sequencing data and the broad scope of downstream tasks mean that a sophisticated and versatile computational method is urgently needed. Here we introduce EpiAgent, a foundation model pretrained on our manually curated large-scale Human-scATAC-Corpus. EpiAgent encodes chromatin accessibility patterns of cells as concise 'cell sentences' and captures cellular heterogeneity behind regulatory networks via bidirectional attention. Comprehensive benchmarks show that EpiAgent excels in typical downstream tasks, including unsupervised feature extraction, supervised cell type annotation and data imputation. By incorporating external embeddings, EpiAgent enables effective cellular response prediction for both out-of-sample stimulated and unseen genetic perturbations, reference data integration and query data mapping. Through in silico knockout of cis-regulatory elements, EpiAgent demonstrates the potential to model cell state changes. EpiAgent is further extended to directly annotate cell types in a zero-shot manner.
Indexed as
Identifiers
40999099What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.